Acute cholangitis

Gigot JF, Leese T, Dereme T, et al. Acute cholangitis: multivariate analysis of risk factors. Ann Surg. 1989 Apr;209(4):435-8.Full text  Abstract

Qureshi WA. Approach to the patient who has suspected acute bacterial cholangitis. Gastroenterol Clin North Am. 2006 Jun;35(2):409-23. Abstract

Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):31-40.Full text  Abstract

Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16.Full text  Abstract

Mayumi T, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):96-100.Full text  Abstract

Mukai S, Itoi T, Baron TH, et al. Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo Guidelines 2018. J Hepatobiliary Pancreat Sci. 2017 Oct;24(10):537-49.Full text  Abstract

1. Boey JH, Way LW. Acute cholangitis. Ann Surg. 1980 Mar;191(3):264-70.Full text  Abstract

2. Edlund G, Ljungdahl M. Acute cholecystitis in the elderly. Am J Surg. 1990 Apr;159(4):414-6;discussion 416. Abstract

3. Rumsey S, Winders J, MacCormick AD. Diagnostic accuracy of Charcot's triad: a systematic review. ANZ J Surg. 2017 Apr;87(4):232-8.Full text  Abstract

4. Alam S, Mustafa G, Ahmad N, et al. Presentation and endoscopic management of biliary ascariasis. Southeast Asian J Trop Med Public Health. 2007 Jul;38(4):631-5. Abstract

5. Carmona RH, Crass RA, Lim RC Jr, et al. Oriental cholangitis. Am J Surg. 1984 Jul;148(1):117-24. Abstract

6. Kimura Y, Takada T, Strasberg SM, et al. TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013 Jan;20(1):8-23.Full text  Abstract

7. Higuchi R, Takada T, Strasberg SM, et al; Tokyo Guideline Revision Committee. TG13 miscellaneous etiology of cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013 Jan;20(1):97-105.Full text  Abstract

8. Pitt HA, Couse NF. Biliary sepsis and toxic cholangitis. In: Moody FG, Carey LC, eds. Surgical treatment of digestive diseases. 2nd ed. Chicago: Year Book Medical Publishers; 1990:332.

9. Gigot JF, Leese T, Dereme T, et al. Acute cholangitis: multivariate analysis of risk factors. Ann Surg. 1989 Apr;209(4):435-8.Full text  Abstract

10. Qureshi WA. Approach to the patient who has suspected acute bacterial cholangitis. Gastroenterol Clin North Am. 2006 Jun;35(2):409-23. Abstract

11. Csendes A, Becerra M, Burdiles P, et al. Bacteriological studies of bile from the gallbladder in patients with carcinoma of the gallbladder, cholelithiasis, common bile duct stones and no gallstones disease. Eur J Surg. Jun-Jul 1994;160(6-7):363-7. Abstract

12. Hanau LH, Steigbigel NH. Acute (ascending) cholangitis. Infect Dis Clin North Am. 2000 Sep;14(3):521-46. Abstract

13. Naseer M, Dailey FE, Juboori AA, et al. Epidemiology, determinants, and management of AIDS cholangiopathy: a review. World J Gastroenterol. 2018 Feb 21;24(7):767-74.Full text  Abstract

14. Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):17-30.Full text  Abstract

15. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10.Full text  Abstract

16. National Institute for Health and Care Excellence. Sepsis: recognition, diagnosis and early management. 13 September 2017 [internet publication].Full text

17. American College of Emergency Physicians (ACEP) Expert Panel on Sepsis. DART: an evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock. 2016 [internet publication].Full text

18. Churpek MM, Snyder A, Han X, et al. Quick sepsis-related organ failure assessment, systemic inflammatory response syndrome, and early warning scores for detecting clinical deterioration in infected patients outside the intensive care unit. Am J Respir Crit Care Med. 2017 Apr 1;195(7):906-11.Full text  Abstract

19. Smith GB, Prytherch DR, Meredith P, et al. The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death. Resuscitation. 2013 Apr;84(4):465-70. Abstract

20. Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med. 2018 Jun;44(6):925-8.Full text  Abstract

21. Nutbeam T, Daniels R on behalf of the UK Sepsis Trust. Sepsis: clinical tools. 2020 [internet publication].Full text

22. Daniels R, Nutbeam T, McNamara G, et al. The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study. Emerg Med J. 2011 Jun;28(6):507-12.Full text  Abstract

23. Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):31-40.Full text  Abstract

24. Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16.Full text  Abstract

25. Les'kiv IM, Moros HS, Mechev DS. Ultrasound diagnostics of jaundice [in Ukrainian]. Lik Sprava. 2005 Apr-May;(3):55-7. Abstract

26. Verma D, Kapadia A, Eisen GM, et al. EUS vs MRCP for detection of choledocholithiasis. Gastrointest Endosc. 2006 Aug;64(2):248-54. Abstract

27. Mayumi T, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):96-100.Full text  Abstract

28. European Medicines Agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. 11 March 2019 [internet publication].Full text

29. Food and Drug Administration. Drug Safety Communication: FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. 20 December 2018 [internet publication].Full text

30. Food and Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. 10 July 2018 [internet publication].Full text

31. Mukai S, Itoi T, Baron TH, et al. Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo Guidelines 2018. J Hepatobiliary Pancreat Sci. 2017 Oct;24(10):537-49.Full text  Abstract

32. Yasuda I, Itoi T. Recent advances in endoscopic management of difficult bile duct stones. Dig Endosc. 2013 Jul;25(4):376-85.Full text  Abstract

33. Mok SR, Mannino CL, Malin J, et al. Does the urgency of endoscopic retrograde cholangiopancreatography (ercp)/percutaneous biliary drainage (pbd) impact mortality and disease related complications in ascending cholangitis? (deim-i study). J Interv Gastroenterol. 2012 Oct;2(4):161-7.Full text  Abstract

34. Parbhu SK, Siddiqui AA, Taylor LJ, et al. Initial report of outpatient management of acute cholangitis via ERCP. Dig Dis Sci. 2017 Jun;62(6):1676-7. Abstract

35. Alkhatib AA, Hilden K, Adler DG. Comorbidities, sphincterotomy, and balloon dilation predict post-ERCP adverse events in PSC patients: operator experience is protective. Dig Dis Sci. 2011 Dec;56(12):3685-8. Abstract

36. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;(1):CD007798.Full text  Abstract

37. Hu B, Wang TT, Wu J, et al. Antireflux stents to reduce the risk of cholangitis in patients with malignant biliary strictures: a randomized trial. Endoscopy. 2014 Feb;46(2):120-6. Abstract

38. Lee KJ, Chung MJ, Park JY, et al. Clinical advantages of a metal stent with an S-shaped anti-reflux valve in malignant biliary obstruction. Dig Endosc. 2013 May;25(3):308-12. Abstract

39. Lin H, Li S, Liu X. The safety and efficacy of nasobiliary drainage versus biliary stenting in malignant biliary obstruction: a systematic review and meta-analysis. Medicine (Baltimore). 2016 Nov;95(46):e5253.Full text  Abstract

40. ASGE Standards of Practice Committee, Chandrasekhara V, Khashab MA, et al. Adverse events associated with ERCP. Gastrointest Endosc. 2017 Jan;85(1):32-47.Full text  Abstract